LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC
LCC in Portuguese: Virtual Tumor Board - EGFR NSCLC by IASLC
11 Heinä 202546min
IASLC_WCLC 2025 Preview
IASLC_WCLC 2025 Preview by IASLC
8 Heinä 202545min
Virtual Tumor Board: Resectable EGFR NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Chunxia Su and Dr. Collin Blakely. The case explores resectable EGFR NSCLC.
1 Heinä 202539min
FDA Approval: Taletrectinib and ROS1 NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of taletrectinib, a next-generation ROS1 kinase inhibitor, for NSCLC with a ROS1 gene fusion. Dr. Enri...
24 Kesä 202529min
IASLC - ASCO 2025 Highlights
ASCO 2025 Highlights Guests: Charu Aggarwal, MD, MPH Leslye M. Heisler Professor of Medicine Section Chief, Thoracic and Head & Neck Cancer Associate Director, Penn Center for Cancer Care Innovation...
6 Kesä 202555min
FDA Approval: Telisotuzumab Vedotin and MET-Positive NSCLC
In this episode, we will discuss the FDA approval of telisotuzumab vedotin, an antibody drug conjugate, for NSCLC with high c-MET expression. To help review the data and offer perspective on this new ...
27 Touko 202533min
LCC in Korean: Lung Cancer Updates & Future Directions
LCC in Korean: Lung Cancer Updates & Future Directions by IASLC
23 Touko 202533min
Global Advances and Persistent Disparities in Lung Cancer Treatment
Global Advances and Persistent Disparities in Lung Cancer Treatment by IASLC
20 Touko 202547min
